Trial Profile
Study of carmustine/bevacizumab in recurrent glioblastoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Carmustine (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 21 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology